US Patent Issued to ME Therapeutics on Sept. 23 for "Anti-G-CSF antibodies and uses thereof" (Canadian Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,308, issued on Sept. 23, was assigned to ME Therapeutics Inc..

"Anti-G-CSF antibodies and uses thereof" was invented by Salim Dhanji (North Vancouver, Canada), John Priatel (Vancouver, Canada), Kenneth Harder (North Vancouver, Canada), Traian Sulea (Kirkland, Canada) and Jason Baardsnes (Montreal).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application discloses methods of making anti-G-CSF antibodies, anti-G-CSF antibodies, methods of screening the activity of anti-G-CSF antibodies, pharmaceutical compositions of anti-G-CSF antibodies, kits containing anti-G-CSF antibodies, and methods of using anti-G-CSF antibodies to treat a diseas...